Defendant Name:
Maurizio Chiriva-Internati
Defendant Type:
Individual
Initial Case Details
Legal Case Name
SEC v. Maurizio Chiriva-Internati
First Document Date
03-Dec-2024
Initial Filing Format
Civil Proceeding
Case Number
24-cv-04729
Allegation Type
Issuer Reporting and Disclosure
Federal District Court
Texas, Southern District of Texas
Affiliations
- Former: Director—Chairman at Kiromic BioPharma, Inc.
- Former: CEO at Kiromic BioPharma, Inc.
- Former: Chief Scientific Officer at Kiromic BioPharma, Inc.
- Current: Founder at Kiromic BioPharma, Inc.
Related Violations Alleged
Maurizio Chiriva-Internati is alleged to have aided and abetted Kiromic BioPharma, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 12b-20 of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted Kiromic BioPharma, Inc.'s violation of Sec 13(a) of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted an unidentified individual or entity's violation of Sec 13(a) of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted Kiromic BioPharma, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 13a-13 of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted Kiromic BioPharma, Inc.'s violation of Rule 13a-15 of the Exchange Act.
Maurizio Chiriva-Internati is alleged to have aided and abetted an unidentified individual or entity's violation of Rule 13a-15 of the Exchange Act.
Resolutions
Bars:
- Bar from acting as Director or Officer of a public company for 3 years
First Resolution Date
20-Dec-2024
Headline Total Penalty and Disgorgement
See Related Documents
